Page last updated: 2024-08-23

simvastatin and Endomyocardial Fibrosis

simvastatin has been researched along with Endomyocardial Fibrosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Monceau, V; Opolon, P; Pasinetti, N; Pouzoulet, F; Schupp, C; Vozenin, MC	1
Abdellatif, M; Entman, ML; Kopelen, HA; Lutucuta, S; Marian, AJ; Nagueh, SF; Patel, R; Quinones, MA; Roberts, R; Tsybouleva, N; Zoghbi, WA	1

Other Studies

2 other study(ies) available for simvastatin and Endomyocardial Fibrosis

Article	Year
Modulation of the Rho/ROCK pathway in heart and lung after thorax irradiation reveals targets to improve normal tissue toxicity. Current drug targets, 2010, Volume: 11, Issue:11 Topics: Amides; Animals; Bleomycin; Connective Tissue Growth Factor; Cytoskeleton; Endomyocardial Fibrosis; Female; Heart; Lung; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Pravastatin; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyridines; Radiation Injuries; Radiation Pneumonitis; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; rho-Associated Kinases; rhoB GTP-Binding Protein; Simvastatin; Smad Proteins; Thorax	2010
Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation, 2001, Jul-17, Volume: 104, Issue:3 Topics: Animals; Animals, Genetically Modified; Cardiomegaly; Cardiomyopathy, Hypertrophic; Cell Line; Disease Models, Animal; Echocardiography; Echocardiography, Doppler; Endomyocardial Fibrosis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Mutation; Myocardium; Myosin Heavy Chains; Phenotype; Rabbits; ras Proteins; Remission Induction; rhoA GTP-Binding Protein; Simvastatin; Ventricular Function, Left	2001

Article

Year

Modulation of the Rho/ROCK pathway in heart and lung after thorax irradiation reveals targets to improve normal tissue toxicity.

Current drug targets, 2010, Volume: 11, Issue:11

Topics: Amides; Animals; Bleomycin; Connective Tissue Growth Factor; Cytoskeleton; Endomyocardial Fibrosis; Female; Heart; Lung; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Pravastatin; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyridines; Radiation Injuries; Radiation Pneumonitis; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; rho-Associated Kinases; rhoB GTP-Binding Protein; Simvastatin; Smad Proteins; Thorax

2010

Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy.

Circulation, 2001, Jul-17, Volume: 104, Issue:3

Topics: Animals; Animals, Genetically Modified; Cardiomegaly; Cardiomyopathy, Hypertrophic; Cell Line; Disease Models, Animal; Echocardiography; Echocardiography, Doppler; Endomyocardial Fibrosis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Mutation; Myocardium; Myosin Heavy Chains; Phenotype; Rabbits; ras Proteins; Remission Induction; rhoA GTP-Binding Protein; Simvastatin; Ventricular Function, Left

2001